Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,400 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cost effectiveness of HMG-CoA reductase inhibition in Canada.
Russell MW, Huse DM, Miller JD, Kraemer DF, Hartz SC. Russell MW, et al. Among authors: miller jd. Can J Clin Pharmacol. 2001 Spring;8(1):9-16. Can J Clin Pharmacol. 2001. PMID: 11283756
Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis.
Singh G, Miller JD, Huse DM, Pettitt D, D'Agostino RB, Russell MW. Singh G, et al. Among authors: miller jd. J Rheumatol. 2003 Apr;30(4):714-9. J Rheumatol. 2003. PMID: 12672188
Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.
Brown JS, Papadopoulos G, Neumann PJ, Friedman M, Miller JD, Menzin J. Brown JS, et al. Among authors: miller jd. Headache. 2005 Sep;45(8):1012-22. doi: 10.1111/j.1526-4610.2005.05182.x. Headache. 2005. PMID: 16109115
Cost-effectiveness of Telaprevir combination therapy for chronic hepatitis C.
Brogan AJ, Talbird SE, Thompson JR, Miller JD, Rubin J, Deniz B. Brogan AJ, et al. Among authors: miller jd. PLoS One. 2014 Mar 6;9(3):e90295. doi: 10.1371/journal.pone.0090295. eCollection 2014. PLoS One. 2014. PMID: 24603445 Free PMC article.
Cost-effectiveness of statins.
Huse DM, Russell MW, Miller JD, Kraemer DF, D'Agostino RB, Ellison RC, Hartz SC. Huse DM, et al. Among authors: miller jd. Am J Cardiol. 1998 Dec 1;82(11):1357-63. doi: 10.1016/s0002-9149(98)00641-9. Am J Cardiol. 1998. PMID: 9856919
Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data.
Miller JD, Foster T, Boulanger L, Chace M, Russell MW, Marton JP, Menzin J. Miller JD, et al. COPD. 2005 Sep;2(3):311-8. doi: 10.1080/15412550500218221. COPD. 2005. PMID: 17146996
Cost-effectiveness analysis of interferon beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosis.
Caloyeras JP, Zhang B, Wang C, Eriksson M, Fredrikson S, Beckmann K, Knappertz V, Pohl C, Hartung HP, Shah D, Miller JD, Sandbrink R, Lanius V, Gondek K, Russell MW. Caloyeras JP, et al. Among authors: miller jd. Clin Ther. 2012 May;34(5):1132-44. doi: 10.1016/j.clinthera.2012.03.004. Epub 2012 Apr 27. Clin Ther. 2012. PMID: 22541587
Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain.
Kwong WJ, Ozer-Stillman I, Miller JD, Haber NA, Russell MW, Kavanagh S. Kwong WJ, et al. Among authors: miller jd. Clin Ther. 2010 Sep;32(10):1768-81. doi: 10.1016/j.clinthera.2010.09.011. Clin Ther. 2010. PMID: 21194601
Economic burden of follicular non-Hodgkin's lymphoma.
Foster T, Miller JD, Boye ME, Russell MW. Foster T, et al. Among authors: miller jd. Pharmacoeconomics. 2009;27(8):657-79. doi: 10.2165/11314820-000000000-00000. Pharmacoeconomics. 2009. PMID: 19712009 Review.
Pharmacoeconomic considerations in treating iron overload in patients with β-thalassaemia, sickle cell disease and myelodysplastic syndromes in the US: a literature review.
Zhang B, Donga PZ, Corral M, Sasane M, Miller JD, Pashos CL. Zhang B, et al. Among authors: miller jd. Pharmacoeconomics. 2011 Jun;29(6):461-74. doi: 10.2165/11589250-000000000-00000. Pharmacoeconomics. 2011. PMID: 21452907 Review.
1,400 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback